Aurobindo Pharma to Acquire Lannett, Gain US Manufacturing Base

Aurobindo Pharma, an Indian drug maker, is buying Lannett Company, a US-based company that makes generic medicines.

The deal is worth $250 million.

Lannett has a manufacturing plant in the US.

This deal helps Aurobindo produce medicines in the US, potentially avoiding any extra costs from tariffs on imported drugs.

This also gives Aurobindo access to government contracts and expands their product range.